Rein Therapeutics Inc. has entered into a new financing agreement with YA II PN, Ltd., a Cayman Islands exempt limited partnership managed by Yorkville. The agreement, known as the Pre-Paid Advance Agreement $(PPA)$, was executed on July 29, 2025. Under the terms of the PPA, Rein Therapeutics can request pre-paid advances from Yorkville totaling up to $6.0 million over a 12-month period, subject to specific conditions. Yorkville purchased an initial advance of $1.0 million on the effective date for net proceeds of $0.95 million. The financing arrangement is designed to support Rein Therapeutics' financial operations and growth initiatives.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。